文献检索，用中文搜 PubMed

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

核心技术专利：CN118964589B侵权必究

Todo S, Furukawa H, Jin M B, Shimamura T

First Department of Surgery, Hokkaido University School of Medicine, Sapporo, Japan.

Liver Transpl. 2000 Nov;6(6 Suppl 2):S66-72. doi: 10.1053/jlts.2000.19009.

Twenty centers in Japan performed 308 living donor liver transplants (LDLT) in adults. 2. Right lobe grafts were used in the minority of cases (27.1%); most had left lobe grafts (72.9%). Survival was not influenced by the type of graft. 3. There were no donor deaths (0%); 9.3% of donors experienced mild to moderate complications. Biliary complications were the most frequent. 4. Overall recipient survival was 72.4%.

日本的20个中心对成人进行了308例活体供肝肝移植（LDLT）。2. 少数病例（27.1%）使用右叶移植物；大多数使用左叶移植物（72.9%）。移植物类型不影响生存率。3. 供体无死亡（0%）；9.3%的供体出现轻至中度并发症。胆道并发症最为常见。4. 受体总体生存率为72.4%。

Todo S, Furukawa H, Jin M B, Shimamura T

First Department of Surgery, Hokkaido University School of Medicine, Sapporo, Japan.

Liver Transpl. 2000 Nov;6(6 Suppl 2):S66-72. doi: 10.1053/jlts.2000.19009.

Twenty centers in Japan performed 308 living donor liver transplants (LDLT) in adults. 2. Right lobe grafts were used in the minority of cases (27.1%); most had left lobe grafts (72.9%). Survival was not influenced by the type of graft. 3. There were no donor deaths (0%); 9.3% of donors experienced mild to moderate complications. Biliary complications were the most frequent. 4. Overall recipient survival was 72.4%.

日本的20个中心对成人进行了308例活体供肝肝移植（LDLT）。2. 少数病例（27.1%）使用右叶移植物；大多数使用左叶移植物（72.9%）。移植物类型不影响生存率。3. 供体无死亡（0%）；9.3%的供体出现轻至中度并发症。胆道并发症最为常见。4. 受体总体生存率为72.4%。